Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea

Alberto Álvarez‐Larrán, Marta Garrote, Francisca Ferrer‐Marín et al.|Cancer|2022

Cited by 32